Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Nearly 600K bottles of blood pressure drug recalled due to carcinogen risk

The FDA has detailed three voluntary recalls for prazosin hydrochloride, a medication used to treat hypertension, due to safety concerns.

cvi42 | Plaque from Circle Cardiovascular Imaging

FDA clears new AI-enabled coronary plaque analysis software

Circle Cardiovascular Imaging, a Canadian medtech company, received the key approval for its cvi42 | Plaque platform.

Thumbnail

Mammography services suspended at 2 hospitals following ACR review

A news release indicates the suspensions are due to breast images not meeting the college's clinical quality standards. 

closing closure going out of business shutter

Consolidation may be driving radiologists away from practicing as generalists

Radiologists who experienced a practice closure are more likely to operate as subspecialists afterward, according to new Neiman research.  

Philips Headquarters

FDA warns Philips after issues arise at multiple manufacturing facilities

Meanwhile, the Amsterdam-based imaging giant said it has already taken action to begin correcting these issues. 

brain stethoscope alzheimer's dementia

FDA accepts application for new Alzheimer’s PET imaging agent from Lantheus

The company is working to commercialize MK-6240, a radiodiagnostic that targets tau protein tangles—a “key hallmark of several neurodegenerative diseases.” 

Recor Medical's Paradise Ultrasound Renal Denervation System

Medicare now covers renal denervation for patients with uncontrolled hypertension

This decision expands access to renal denervation to many more patients throughout the United States. Recor Medical and Medtronic both gained FDA approval for their RDN systems in 2023, and other vendors are actively developing their own treatment options.

Thumbnail

Former CEO of Unite Us tapped as CMS’ Medicaid and CHIP lead

Dan Brillman, the former CEO and co-founder of coordinated care support service Unite Us, has left his position for a role in the Centers for Medicare & Medicaid Services, where he will be responsible for overseeing the federal government's safety net healthcare programs.